COMPANY PROFILE

Eris Lifesciences

Explore full profile

Domestic pharmaceutical company focused on a wide range of products in the chronic and acute therapy segments

Ahmedabad, IndiaFounded 2007Biotech & Life Sciences

Valuation $2.87B Market cap · Aug/2026

Revenue $423M Latest reported FY

EBITDA $153M Latest reported FY

At a glance

Status: Listed
Founded: 2007
Headquarters: Ahmedabad, India
Listing: IPO 2017
Sector: Biotech & Life Sciences
Power Law: Thoroughbred$100M+ revenue

Knowledge graph

Founder mafia, market maps, research and news connected to this company by Dealroom

Investors

1 investor on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Series B and later1 investor entered at this stage

CCChrys Capital

Talent

Book a demo to see the people

Founders /100 quality score

Key operators quality score

Potential founders likely future founders

Startup mafia alumni-founded startups

Talent movements in · out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country

Workforce by country

12 countries with
team presence

🇮🇳 India98.6%

🇦🇪 United Arab Emirates0.4%

🇬🇧 United Kingdom0.3%

🇺🇸 United States0.1%

🇦🇺 Australia0.1%

Top 5 of 12 shown

Web traffic by country

13K monthly visits
across markets

🇮🇳 India103.1%

Top 1 markets shown

Investments and acquisitions

Disclosed deals where Eris Lifesciences was the backer or acquirer, 2017–2024. Toggle between venture rounds, M&A, or both. The map below is grouped by the target company's sector — the colored pill on each chip is the round type.

Portfolio analysis

4 deals across Eris Lifesciences's capital deployment.

Where the deals concentrate by sector, stage, and decade.

By sectorCount

By stageCount

By periodCount